ModivCare (MODV) files NT 10-Q; Q3 2025 results seen lower
ModivCare Inc. filed a Form 12b-25 (NT 10-Q) for the quarter ended September 30, 2025, notifying a late filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ModivCare Inc. filed a Form 12b-25 (NT 10-Q) for the quarter ended September 30, 2025, notifying a late filing. The company needs more time to complete its ongoing goodwill impairment assessment, to evaluate results of an investigation conducted by outside counsel at the Audit Committee’s direction, and to finalize documentation and reviews amid competing demands tied to its previously disclosed Chapter 11 bankruptcy.
ModivCare anticipates that consolidated revenue and net income (loss) for the quarter ended September 30, 2025 will be significantly lower than the comparable period last year, due in part to reorganization expenses and professional fees approved by the Bankruptcy Court in connection with its Chapter 11 Cases. The company also noted it has not filed its Form 10‑Q for the quarter ended June 30, 2025.
Positive
- None.
Negative
- Late 10-Q filing due to ongoing assessments and documentation amid Chapter 11
- Q3 2025 revenue and net income (loss) expected significantly lower due in part to reorganization expenses and court‑approved fees
Insights
Late 10-Q and Chapter 11 pressures point to weaker Q3.
ModivCare flagged a delay in its Q3 report while working through a goodwill impairment assessment and review of an investigation overseen by the Audit Committee. Management bandwidth is constrained by previously disclosed Chapter 11 proceedings, which can slow financial close and add professional fee burdens.
The company states Q3 results for the period ended September 30, 2025 will be “significantly lower” than last year, citing reorganization expenses and court‑approved professional fees. This suggests compressed margins and potential net losses depending on the magnitude of these costs.
Watch the forthcoming Q3 2025 filing for any recorded goodwill impairment and the quantified impact of reorganization expenses. Actual cash outlays and any impairment charges will drive near‑term balance sheet and earnings dynamics once disclosed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ModivCare (MODV) file?
Why is MODV’s Q3 2025 10-Q delayed?
How does MODV expect Q3 2025 results to compare to last year?
What is contributing to weaker Q3 2025 results for MODV?
Has MODV missed other reports recently?
Does the NT 10-Q specify when the Q3 2025 report will be filed?
AI-generated analysis. How Rhea-AI works. Not financial advice.